Tuesday, April 26, 2016

Valeant Was Too Aggressive in Raising Drug Prices, CEO Says

Valeant Pharmaceuticals International Inc. has made mistakes and been too aggressive in the past in dramatically boosting ​the ​price​ of some of its drugs, the company’s outgoing chief executive is expected to tell a Senate committee Wednesday.

from WSJ.com: US Business http://ift.tt/1Wp0BZz
via IFTTT

No comments:

Post a Comment